EcoDrugPlus

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSTNIG00000004541
Gene Symbol: KEAP1B
2 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor (A Type Iii Receptor Tyrosine Kinase)

Ensembl ID : ENSTNIG00000017655
Gene Symbol: KDR
2 Cross references
196 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSTNIG00000018683
Gene Symbol: KIF11
2 Cross references
201 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSTNIG00000007968
Gene Symbol: KIF5B
3 Cross references
236 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSTNIG00000008770
Gene Symbol: KIF5B
3 Cross references
234 Possible Orthologues:

Lectin, Galactoside Binding Soluble 3a

Ensembl ID : ENSTNIG00000019342
Gene Symbol: LGALS3A
2 Cross references
220 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSTNIG00000003351
Gene Symbol: LTA4H
2 Cross references
202 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSTNIG00000000836
Gene Symbol: LTA4H
2 Cross references
202 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSTNIG00000007431
Gene Symbol: LTB4R
2 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 2a

Ensembl ID : ENSTNIG00000007432
Gene Symbol: LTB4R2A
2 Cross references
157 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSTNIG00000017255
Gene Symbol: KDM1A
2 Cross references
212 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSTNIG00000011004
Gene Symbol: LOXL2A
2 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).